Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study.
暂无分享,去创建一个
A. Shaw | S. Peters | D. Camidge | Dong-Wan Kim | S. Gadgeel | E. Pozzi | S. Ignatius Ou | Ting Liu | J. Noé | K. Konopa | I. Loftin | T. Mok | C. Williams